FINANCIALS

As of December 31, 2015, NanoLogix has 140,181,530 outstanding shares issued.

Please Note: 

  • Infectech is the former name of NanoLogix, Inc.
  • Included in each time period: Balance Sheet, Statement of Operations, Statement of Stockholders Deficit and Statement of Cash Flow.

2014-2013

Financial_Statements_3-31-2014

Financial Statements 6-30-2014

Financial Statements 9-30-2014

 

2013-2012

Financial_Statements_3-31-2013

Financial_Statements_6-30-2013

Financial_Statements_9-30-2013

Financial_Statements_12-31-2013

 

2012-2011

March 31, 2012 and 2011

June 30, 2012 and 2011

September 30, 2012 and 2011

4th Qtr Financials 2012

 

2011-2010

March 31, 2011 and 2010

June 30, 2011 and 2010

September 30, 2011 and 2010

December 31, 2011 and 2010

 

2010-2009

March 31, 2010 and 2009

June 30, 2010 and 2009

September 30, 2010 and 2009

December 31, 2010 and 2009

 

2009-2008

June 30, 2009 and 2008

September 30, 2009 and 2008

December 31, 2009 and 2008

 

2008-2007

December 31, 2008 and 2007

September 30, 2008 and 2007

June 30, 2008 and 2007

March 31, 2008 and 2007

 

2007-2006

December 31, 2007 and 2006

September 30, 2007 and 2006

June 30, 2007 and 2006

March 31, 2007 and 2006

 

2006-2005

Statement of Operations 2006 and 2005

Statement of Cash Flow 2006 and 2005

Balance Sheet 2006 and 2005

Statement of Shareholder Equity/Deficit 1989 through 2006

 

2005-2004

Statement of operations 2005 and 2004

Statement of Cash Flow 2005 and 2004

Balance Sheet 2005 and 2004

Statement of Shareholder Equity/Deficit 1989 and 2005

 

2004-2003

Statement of Operations 2004 and 2003

Statement of Cash Flow 2004

Balance Sheet 2004 and 2003

Statement of Shareholder Equity/Deficit 1989 through 2004